NASDAQ · Key Statistics

Windward Bio Group AG (WWB) P/E Ratio, ROE & Key Statistics

$31.00 NASDAQ: WWB Market Cap $478.67M

Data as of Nov 16, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Windward Bio Group AG (WWB), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

MetricValue
P/B ratioShare price divided by book value per share.1.67
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.-20.09

Profitability

MetricValue
Gross marginRevenue left after the direct cost of goods sold.0.00%
Operating marginRevenue left after operating costs.0.00%
Net marginRevenue left after every cost, including tax and interest.0.00%

Financial health

MetricValue
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.8.57
Quick ratioThe same, excluding inventory.8.49
Debt to equityTotal borrowings against shareholders’ equity.0.00

Per share and size

MetricValue
Market capitalisationShare price times shares outstanding.$478.67M

Windward Bio Group AG (WWB) statistics — frequently asked questions

How much debt does Windward Bio Group AG carry?

Windward Bio Group AG (WWB) has a debt-to-equity ratio of 0.00, which compares total borrowings with shareholders' equity.

P/E and ROE of other Medical - Pharmaceuticals stocks

RPRX P/E 41.25CORT P/E 49.69LQDA key statisticsPBH P/E 13.90QUIT ROE -225.39%HITI ROE -36.06%NSRX ROE -158.83%All Medical - Pharmaceuticals stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.